Overview of Dextrose monohydrate

Property	Description
Active ingredient	Dextrose (D-glucose)
Form	Solution for infusion/injection, Oral solutions, Gels, Tablets
Pharmacological class	Glucose-Elevating Agent, Nutritional Supplement
General Purpose	Provides immediate metabolic energy and restores blood sugar
Origin	Naturally derived (from starch), Monosaccharide

Identity and Classification

Dextrose monohydrate is the scientific term for the precise crystalline form of D-glucose, the essential monosaccharide that functions as the body's primary fuel source. As a medicinal compound, it is classified pharmacologically as a Glucose-Elevating Agent and a high-level Nutritional Supplement. This substance functions to rapidly correct diminished carbohydrate status. The active ingredient, often simply referred to as Dextrose, is a carbohydrate that is naturally derived, typically produced through the purification of starch, often sourced from corn. Its chemical structure is notable for including one water molecule (monohydrate), a feature that ensures its purity and stability for pharmaceutical applications, distinguishing it from its anhydrous counterpart. Dextrose possesses a rapid absorption profile, which supports its utility as a quick-acting source of calories.

Available Forms and General Purpose

Dextrose monohydrate is prepared for patient use in multiple versatile dosage form(s), including sterile Intravenous (IV) solutions for injection and infusion, as well as various oral solutions, gels, and tablets. This drug is used as a single-ingredient product available for both Parenteral (administered by IV) and Oral routes of administration, making it highly adaptable for use in acute settings and for patient self-administration. The medicine's fundamental purpose is to immediately provide the body with essential metabolic energy, acting as a rapid nutrient replenisher. Dextrose solutions are used as sources of water and calories in Total Parenteral Nutrition. By introducing readily available D-glucose, its core function is to ensure that critical organs have the fuel they require, supporting a crucial protein-sparing action by supplying necessary carbohydrate calories.

What side effects are possible with Dextrose monohydrate?

Possible Side Effects and Safety Information

The regulatory safety profile of Dextrose Monohydrate, particularly the intravenous solution, is defined by the potential for metabolic imbalances and local administration issues, as documented by official government health authorities.

Adverse Reaction Categories

Adverse reactions are officially classified across several System-Organ Classes. The two primary categories noted are Metabolism and Nutrition Disorders and General Disorders and Administration Site Conditions.

Metabolic Effects include hyperglycemia (elevated blood glucose) and disturbances in electrolyte balance, such as hyponatremia and hypophosphatemia.
Administration Site Effects include local phlebitis (vein inflammation), thrombosis (clot formation), infection at the injection site, and pain.

Frequency classifications for these effects are often listed as Not Known or Uncommon in primary regulatory documents, as incidence is highly dependent on the solution concentration, rate of infusion, and the patient's underlying condition.

Serious Adverse Reactions and Safety Constraints

Regulatory labels document the risk of serious complications, which can include Pulmonary Edema resulting from fluid overload, and Hyperosmolar Hyperglycemic State following rapid or excessive administration. Severe Anaphylaxis (hypersensitivity reaction) is also listed.

Use is formally contraindicated in specific medical situations, such as patients with certain types of Intracranial or Intraspinal Hemorrhage and in cases of Clinically Significant Hyperglycemia.

Specific Population Safety Considerations are noted for vulnerable groups. Pediatric patients, especially neonates, and patients with cardiac or renal impairment require close monitoring due to increased risk of severe fluid and electrolyte imbalances. Furthermore, the official label notes that effects may be linked to the rate and duration of administration.

Overdose and Emergency Response

Overdose with Dextrose monohydrate solutions is officially documented in regulatory information as a result of administering the compound at a rate or volume exceeding the body’s metabolic capacity for glucose utilization or fluid processing. This excessive administration can lead to severe metabolic disturbances and fluid imbalances. Documented manifestations include hyperglycemia, the development of a Hyperosmolar Hyperglycemic State (HHS), and profound electrolyte imbalances, notably hyponatremia. These conditions may present with symptoms such as mental confusion or loss of consciousness. Severe outcomes officially associated with overdose include pulmonary edema, coma, and death, alongside specialized risks such as acute hyponatremic encephalopathy. Regulatory guidance mandates specific actions in the event of suspected overdose or a hypersensitivity reaction. Individuals must stop administration immediately and seek emergency medical attention. Overdose management is categorized as primarily symptomatic and supportive, requiring continuous monitoring of blood glucose levels and electrolyte concentrations. Furthermore, regulatory labeling specifies that patients with underlying Central Nervous System disease, renal impairment, and neonates have an increased susceptibility to these adverse overdose effects.

Therapeutic Uses of Dextrose monohydrate

Understanding Dextrose Monohydrate

Dextrose monohydrate is a simple sugar, chemically identical to glucose, which serves as a primary source of energy for the body's cells. It is commonly utilized in medical settings to address various conditions related to energy depletion, fluid loss, and metabolic imbalances.

Main Therapeutic Uses

Treatment of Hypoglycemia

The most frequent application of dextrose monohydrate is the rapid reversal of hypoglycemia, a condition characterized by abnormally low blood sugar levels. Because it is a simple carbohydrate, the body can absorb it quickly into the bloodstream, providing an immediate source of fuel for the brain and muscles. This is particularly vital in acute clinical situations where blood sugar must be stabilized quickly.

Fluid and Electrolyte Replenishment

Dextrose monohydrate is often administered in intravenous solutions to help restore fluid balance. In cases of dehydration resulting from illness or physical exertion, it provides both water and calories. When combined with sodium chloride or other electrolytes, it helps maintain osmotic pressure and supports the body's hydration levels.

Nutritional Support

For patients who are unable to consume or digest food orally, dextrose monohydrate serves as a critical component of parenteral nutrition. It provides the necessary carbohydrates to meet the body’s metabolic demands, helping to prevent the breakdown of muscle protein for energy (protein-sparing effect) during recovery from surgery, trauma, or chronic illness.

Key Benefits

Rapid Energy Delivery: As a monosaccharide, it requires no digestion and enters the systemic circulation rapidly to provide instant cellular energy.
Metabolic Support: By providing a direct source of glucose, it helps maintain proper metabolic function and prevents the formation of excess ketones, which can occur when the body burns fat for fuel instead of sugar.
Versatility in Administration: It can be formulated in various concentrations, allowing healthcare providers to tailor treatment based on whether a patient needs simple hydration or a highly concentrated energy source.
Compatibility: Dextrose solutions are frequently used as vehicle for the administration of other compatible medications, ensuring they are diluted appropriately for safe delivery into the bloodstream.

Regulatory References

Dextrose Injection prescribing information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Dextrose monohydrate — official regulatory information

Category	Official Eligibility Status (Based on Regulatory Labeling)
Populations for whom use is allowed	Adults, Older Adults, and the entire Pediatric Population (including neonates) are approved for use.
Populations for whom use is contraindicated	Patients with clinically significant hyperglycemia or hyperosmolar states; Individuals with known hypersensitivity to dextrose or corn products; and patients with intracranial or intraspinal hemorrhage or severe dehydration (for hypertonic solutions).
Age-related eligibility rules	Use is established across all age groups. Neonates and infants require heightened caution and close glucose monitoring to manage the risk of hypo- or hyperglycemia.
Condition-specific eligibility rules	Conditional use applies to patients with overt Diabetes Mellitus, requiring concurrent insulin administration. Caution is mandated for patients with impaired renal function or those at risk for fluid and/or solute overload.
Pregnancy and lactation eligibility status	Use is permitted when clinically indicated; appropriate administration is not expected to cause adverse developmental outcomes.

Connection to the overall eligibility profile

Regulatory documents define eligibility primarily through metabolic status and fluid balance. Use is absolutely prohibited in cases of uncontrolled high blood sugar, severe dehydration, or specific conditions like cerebral hemorrhage. The medicine is permitted for all age groups, but official restrictions necessitate continuous monitoring and specific management strategies for populations with diabetes or impaired cardiac or renal function.

What should I know about interactions with other medicines?

Dextrose monohydrate Interactions with other medicines and products

The official regulatory profile for Dextrose monohydrate is structured around procedural incompatibilities and pharmacodynamic effects on systemic homeostasis, with little documentation of metabolic enzyme interactions. Official documents define strict rules concerning administration and co-medication to maintain patient safety and stability.

Official Interaction Statements

Administration Incompatibility: Simultaneous co-administration with blood products (such as whole blood) through the same intravenous infusion set is prohibited. This restriction is a mandatory measure to avoid physical incompatibility, which could result in pseudoagglutination or hemolysis.
Glycemic and Fluid Modulators: The use of Dextrose alongside products that affect glycemic control (e.g., insulin) or fluid and electrolyte balance requires close clinical attention. Co-administration with certain medicines associated with hyponatremia (e.g., specific diuretics or antidepressants) may increase the risk of low serum sodium concentrations, necessitating careful monitoring.
Substance Accumulation Risk: A specific risk involves the accumulation of aluminum present in the solution upon prolonged administration. The risk of reaching toxic levels is heightened in specific patient populations, particularly neonates, low-birth weight infants, and individuals with renal impairment, due to their reduced ability to clear the substance.
Condition-Dependent Restriction: The administration of Dextrose is restricted in acute settings for thiamine-deficient patients (a state often observed in alcohol withdrawal). This restriction is necessary due to the documented potential to precipitate or exacerbate severe neurological complications.

Mechanism of Action

Dextrose monohydrate is chemically identical to D-glucose, the primary monosaccharide that serves as the central metabolic fuel for mammalian cells. Its mechanistic action begins with rapid absorption across the gastrointestinal epithelium via specialized transporter proteins, primarily SGLT1 and GLUT2. Once in the systemic circulation, the molecular structure of D-glucose allows it to immediately enter the glycolytic pathway in the cytoplasm of cells throughout the body.

The entry of glucose into most cell types, notably muscle and adipose tissue, is facilitated by the GLUT4 transporter, which is highly regulated by the hormone insulin. Within the cell, glucose is immediately phosphorylated to glucose-6-phosphate by hexokinase, a critical, irreversible step that traps the molecule inside the cell and commits it to catabolism. This process initiates the primary cascade for adenosine triphosphate (ATP) generation.

The physiological consequence of this rapid uptake is a direct and immediate contribution to the body's circulating plasma glucose pool. This influx of readily available substrate alters the cellular energy status, supplying the necessary fuel to maintain fundamental cellular processes, including membrane potential and active transport. This action serves to directly modulate systemic glucose homeostasis.

Dosage and Administration Information

Dextrose monohydrate is administered through two main official routes: Intravenous (IV) infusion or injection for systemic use, and Oral administration for solutions, gels, or tablets. The intravenous route is utilized for all solution concentrations, but solutions with an osmolarity greater than 900 mOsm/L (such as the 50% solution) must be administered into a central vein to reduce the risk of venous irritation, while lower concentrations, like the 5% solution, may be delivered peripherally.

Official Dosing and Administration Patterns

For acute IV administration in adults and pediatric patients over 12 years, the typical dose is 10 to 25 grams of dextrose, given as a single injection. When used for nutritional support, the dosage and frequency are highly individualized and administered as a continuous IV infusion based on caloric requirements.

Pediatric patients under two years of age receive a lower, weight-based initial IV dose of 250 mg/kg to 500 mg/kg of a 25% solution, delivered via a slow intravenous injection into a central vein.

Procedural Conditions

All intravenous products must be visually inspected for any particulate matter or discoloration prior to use, and any unused portion from single-dose containers must be discarded. Infusion must proceed slowly, and the solution must not be administered simultaneously with blood products through the same infusion set.

Recent Clinical Evidence

Dextrose Monohydrate: Recent Clinical Evidence

Dextrose monohydrate is the hydrated form of D-glucose, a naturally occurring monosaccharide that serves as the body's primary energy source. Clinical use of dextrose is primarily focused on restoring blood glucose levels and providing a source of fluid and calories.

Clinical Applications and Indications

Research and regulatory approvals support the use of dextrose in several key clinical scenarios:

Hypoglycemia Treatment: Concentrated dextrose solutions (e.g., 50%) are indicated for the immediate, symptomatic treatment of low blood sugar, often in emergency settings, to restore serum glucose levels rapidly.
Nutritional Support: Dextrose solutions, typically in lower concentrations (e.g., 5% or 10%), are used as a component of intravenous (IV) solutions to supply water and carbohydrate calories to patients who have restricted oral intake or require parenteral nutrition.
Fluid and Electrolyte Balance: Lower concentration solutions help to maintain hydration and may be used as a vehicle for administering compatible medications.

Supporting Research and Trial Findings

Recent investigations have explored specific applications and the metabolic effects of dextrose administration:

Area of Research	Key Findings Reported in Trials
Pediatric Analgesia	Studies evaluated oral dextrose solutions for reducing behavioral distress during minor painful procedures in infants, noting a statistically significant difference in pain-related behaviors versus control.
Fluid Therapy in Dehydration	Research examined the metabolic effects of dextrose-supplemented saline in dehydrated patients, finding that the addition of dextrose was associated with a reduction in ketosis and may affect metabolic balance.

It is recognized that the compound is rapidly metabolized and utilized by body tissues. Clinical administration requires careful monitoring of blood glucose and electrolyte concentrations, particularly in patients with pre-existing conditions like diabetes or fluid imbalance, to avoid complications such as hyperglycemia or fluid overload.

Frequently Asked Questions (FAQ)

Common questions about Dextrose monohydrate (FAQ)

Q: Is Dextrose monohydrate a prescription drug?

Official documentation, such as the DailyMed and FDA drug labels, typically classifies Dextrose monohydrate injection solutions as a Human Prescription Drug product. This classification indicates that its use is managed within a medical setting.

Q: Are there different strengths of Dextrose monohydrate products?

Yes, official drug labels list various strengths available for Dextrose solutions, especially for intravenous use. These range from lower concentrations, such as 5% and 10%, which may be used for hydration, up to higher concentrations like 25% and 50% (500 mg/mL) for correcting low blood sugar in acute settings.

Q: Is Dextrose monohydrate gluten-free?

Regulatory standards recognize that Dextrose is a highly purified product, commonly derived from starch. The extensive purification process typically removes all proteins, including gluten, making the substance acceptable under most gluten-free considerations.

Q: Is it possible to take too much Dextrose monohydrate?

Official warnings indicate that administration that is too fast or excessive can lead to serious complications. Specifically, it may result in elevated blood sugar (hyperglycemia) and a dangerous condition known as Hyperosmolar Hyperglycemic State. For this reason, administration requires careful management by a healthcare provider.

Q: Is Dextrose monohydrate the only form of sugar used in medicine?

Official information defines Dextrose as D-glucose, the primary sugar the body uses for fuel. While it is the most widely used simple sugar for quickly correcting blood sugar and providing energy, other carbohydrates and sugar compounds are also utilized in medical formulations, particularly in nutritional support.

Q: Is Dextrose monohydrate naturally occurring?

Official sources describe Dextrose monohydrate as the stable, crystalline form of D-glucose. D-glucose itself is a naturally occurring sugar that is essential to the body, serving as the primary source of energy for most cells.

Q: Is Dextrose monohydrate derived from a specific plant source?

Official documents state that Dextrose is manufactured through the purification of starch. The starch source is often corn, though other plant sources may be used for production.

Q: What is the role of Dextrose monohydrate in parenteral nutrition?

According to official drug labels, the role of Dextrose in parenteral nutrition (IV feeding) is to serve as a concentrated source of carbohydrate calories and water. This energy source helps to support the body’s metabolic needs and acts to spare body protein from being used as fuel.

Q: Can Dextrose monohydrate affect blood pressure?

While official warnings do not directly list blood pressure changes as a side effect, the medication can cause fluid-related issues. Administration is associated with risks like fluid overload (potentially leading to pulmonary edema) and disturbances in electrolyte balance, conditions which may require monitoring of circulatory function.

Q: Is Dextrose monohydrate subject to any special restrictions?

Yes, regulatory documents impose specific restrictions concerning administration. A key constraint is the mandatory rule that Dextrose solutions must not be administered simultaneously with blood products through the same IV line due to the risk of physical incompatibility.

Q: What are the non-drug substances that may interact with Dextrose monohydrate?

The official interaction profile notes that co-administration with blood products is prohibited due to incompatibility. Additionally, a warning is included about the risk of aluminum accumulation within the solution upon prolonged use, a factor that requires monitoring in at-risk patients like neonates.

Q: Why is Dextrose monohydrate classified as a 'high-calorie' substance?

The drug label describes concentrated Dextrose solutions as a concentrated source of carbohydrate calories. This classification is due to the key nutritional property of Dextrose, which contributes approximately 3.4 kcal/g, making it an efficient source of energy when administered intravenously.

Q: Does Dextrose monohydrate need to be stored in a special way?

Official guidelines define specific storage requirements, especially for the injection solution. It should be stored at controlled room temperature (typically 20 C to 25 C), protected from both freezing and excessive heat, and kept securely out of the reach of children.

Q: How is Dextrose monohydrate related to the body's metabolism?

Dextrose, as D-glucose, is fundamentally related to metabolism by being the body's primary energy substrate. It restores blood glucose levels and is immediately used by cells to generate energy through the glycolytic pathway. Its primary purpose is to ensure critical organs have the necessary metabolic fuel.

Q: What are common patient misunderstandings about Dextrose monohydrate?

Clinical reviews indicate that this point requires clarification regarding IV fluid classification. While some Dextrose solutions may be hyperosmolar initially, the glucose is rapidly metabolized in the body, which can make the solution physiologically hypotonic in effect.

Q: Are there ongoing clinical trials for new uses of Dextrose monohydrate?

Official clinical trial databases show that Dextrose monohydrate is sometimes used as an inactive comparator (placebo) in ongoing studies for other medical conditions. These trials are typically aimed at testing new therapies, with Dextrose serving as a neutral baseline.

Q: Can the use of Dextrose monohydrate be traced back to historical medical practice?

While Dextrose monohydrate as a purified drug is a modern pharmaceutical product, the medical importance of glucose is rooted in historical practice. The recognition of glucose as a critical biological component and its subsequent chemical isolation and medical use date back to the 19th century.

Q: What are the eligibility criteria described in official documents for Dextrose monohydrate use?

Official eligibility criteria are defined primarily by a patient’s existing metabolic and fluid balance. Use is strictly prohibited in cases like clinically significant hyperglycemia (high blood sugar), known hypersensitivity to corn products, and specific types of bleeding like intracranial hemorrhage. Caution is also required for patients with impaired renal function.

How should Dextrose monohydrate be stored and disposed of?

How to Store and Dispose of Dextrose Monohydrate

Official regulatory guidelines define specific conditions for storing and disposing of Dextrose Monohydrate, which may be supplied as an injection solution or powder.

Storage Requirement	Conditions
Temperature (Injection)	Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection	Protect injections from freezing and excessive heat; keep powder tightly closed, dry, and away from incompatible materials.
Handling	Visually inspect the injection for particulate matter or discoloration before use.
Child Safety	Keep the product out of the reach of children.

For disposal, the unused portion of the injection must be discarded. The powder and empty containers should not be released into drains, sewers, or the general environment. Disposal must be completed according to established local and national waste management regulations.

Dextrose monohydrate